-+ 0.00%
-+ 0.00%
-+ 0.00%

BRAINSWAY RECEIVES FDA CLEARANCE OF DEEP TMS™ AS ADJUNCT THERAPY FOR MAJOR DEPRESSIVE DISORDER (MDD) IN ADOLESCENTS AGED 15 TO 21

Reuters·11/13/2025 11:00:00

Please log in to view news